Zentalis Pharmaceuticals ... (ZNTL)

NASDAQ: ZNTL · Real-Time Price · USD

1.45

0.00 (0.00%)

At close: May 02, 2025, 3:59 PM

1.45

0.00%

After-hours: May 02, 2025, 04:05 PM EDT

Zentalis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-165.87M	-292.19M	-237.11M	-166.09M	-118.55M	-46.38M	-23.43M
Depreciation & Amortization	1.29M	1.39M	1.43M	544K	160K	111K	51K
Stock-Based Compensation	67.27M	54.82M	46.84M	35.74M	23.15M	617K	308K
Other Working Capital	6.48M	-5.05M	-2.27M	1.35M	-667K	115K	-40K
Other Non-Cash Items	-57.01M	23.15M	12.61M	-38.38M	556K	-7.78M	-2.37M
Deferred Income Tax	n/a	-853K	-769K	-2.46M	17K	7.78M	2.37M
Change in Working Capital	-16.54M	5.86M	13.25M	16.56M	7.84M	6.51M	-1.18M
Operating Cash Flow	-170.86M	-207.82M	-163.75M	-154.09M	-86.83M	-39.14M	-24.25M
Capital Expenditures	-221K	-583K	-2.55M	-6.11M	-758K	-352K	-227K
Cash Acquisitions	n/a	n/a	111.63K	-14.32M	18.42M	n/a	n/a
Purchase of Investments	-127.96M	-549.18M	-533.16M	-363.51M	-400.98M	n/a	n/a
Sales Maturities Of Investments	304.68M	505.31M	421.53M	365.82M	116.91M	n/a	n/a
Other Investing Acitivies	65K	n/a	-111.63K	-12.01K	-18.42M	n/a	n/a
Investing Cash Flow	176.56M	-44.46M	-114.18M	-18.11M	-284.83M	-352K	-227K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-241K	n/a	n/a	-1.15M	18.42M	-46K	n/a
Financial Cash Flow	108K	237.3M	261.04M	178.52M	360.44M	81.83M	9.47M
Net Cash Flow	5.81M	-14.98M	-16.89M	6.31M	-11.22M	42.34M	-15.01M
Free Cash Flow	-171.08M	-208.41M	-166.3M	-160.2M	-87.58M	-39.49M	-24.48M